Who are Quest Diagnostics's decision-makers?
Quest Diagnostics is led by Jim Davis. Sellers should map decisions across the executive sponsor, business-unit owner, procurement, legal, security, privacy, compliance, finance, clinical or scientific stakeholders, and implementation owners.
- CEO
- Jim Davis
- CFO/key exec
- Sam Samad
- Founded
- 1967
- Employees
- 55,000+
- HQ
- Secaucus, NJ
- Status
- NYSE: DGX
- Jim DavisChairman, Chief Executive Officer and PresidentCEO since 2022Leads diagnostic information services, health-system partnerships, and advanced diagnostics.
- Sam SamadExecutive Vice President and Chief Financial OfficerCFO since 2022Oversees finance, M&A, and capital allocation.
- Cecilia McKenneySenior Vice President and Chief Human Resources OfficerSenior executiveLeads people strategy across a large distributed workforce.
- Catherine T. DohertySenior Vice President, Regional BusinessesBusiness leaderLeads regional diagnostic operations.
Who leads Quest Diagnostics?
Quest Diagnostics's leadership team combines enterprise healthcare operations, finance, R&D, clinical, product, technology, legal, manufacturing, and commercial roles. The CEO and CFO set capital priorities, while business-unit leaders decide which operational problems become funded initiatives.
Who actually makes buying decisions at Quest Diagnostics?
Buying decisions usually start with a business-unit sponsor, then move through procurement, finance, legal, information security, privacy, compliance, quality, and implementation owners. Clinical, reimbursement, regulatory, or scientific stakeholders become essential whenever the purchase touches patient care, regulated data, clinical evidence, medical products, lab workflows, or payer/provider economics.
How is Quest Diagnostics organized as it scales?
Quest Diagnostics operates through product, therapeutic-area, regional, manufacturing, commercial, and corporate functions. That creates multiple entry points, but enterprise standards for security, privacy, compliance, contracting, vendor risk, and data governance can still control the final approval path.
As of June 2026.Sources:Quest Diagnostics leadershipQuest Diagnostics annual reports
Quest Diagnostics — frequently asked questions
